Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing

被引:179
作者
Mengstie, Misganaw Asmamaw [1 ]
Wondimu, Belay Zawdie [2 ]
机构
[1] Debre Tabor Univ, Coll Med & Hlth Sci, Dept Biomed Sci, Div Biochem, Debre Tabor, Ethiopia
[2] Jimma Univ, Inst Hlth, Dept Biomed Sci, Div Biochem, Jimma, Ethiopia
关键词
CRISPR; Cas-9; sgRNA; gene-editing; mechanism; applications; CRISPR/CAS9; CRISPR-CAS9; TALEN; GENE; CFTR;
D O I
10.2147/BTT.S326422
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clustered regularly interspaced short palindromic repeat (CRISPR) and their associated protein (Cas-9) is the most effective, efficient, and accurate method of genome editing tool in all living cells and utilized in many applied disciplines. Guide RNA (gRNA) and CRISPR-associated (Cas-9) proteins are the two essential components in CRISPR/Cas-9 system. The mechanism of CRISPR/Cas-9 genome editing contains three steps, recognition, cleavage, and repair. The designed sgRNA recognizes the target sequence in the gene of interest through a complementary base pair. While the Cas-9 nuclease makes double-stranded breaks at a site 3 base pair upstream to protospacer adjacent motif, then the double-stranded break is repaired by either non-homologous end joining or homology-directed repair cellular mechanisms. The CRISPR/Cas-9 genome-editing tool has a wide number of applications in many areas including medicine, agriculture, and biotechnology. In agriculture, it could help in the design of new grains to improve their nutritional value. In medicine, it is being investigated for cancers, HIV, and gene therapy such as sickle cell disease, cystic fibrosis, and Duchenne muscular dystrophy. The technology is also being utilized in the regulation of specific genes through the advanced modification of Cas-9 protein. However, immunogenicity, effective delivery systems, off-target effect, and ethical issues have been the major barriers to extend the technology in clinical applications. Although CRISPR/Cas-9 becomes a new era in molecular biology and has countless roles ranging from basic molecular researches to clinical applications, there are still challenges to rub in the practical applications and various improvements are needed to overcome obstacles.
引用
收藏
页码:353 / 361
页数:9
相关论文
共 75 条
  • [21] A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing
    Fajrial, Apresio K.
    He, Qing Qing
    Wirusanti, Nurul, I
    Slansky, Jill E.
    Ding, Xiaoyun
    [J]. THERANOSTICS, 2020, 10 (12): : 5532 - 5549
  • [22] Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
    Fortunato, Fernanda
    Rossi, Rachele
    Falzarano, Maria Sofia
    Ferlini, Alessandra
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 21
  • [23] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
    Frangoul, H.
    Altshuler, D.
    Cappellini, M. D.
    Chen, Y-S
    Domm, J.
    Eustace, B. K.
    Foell, J.
    de la Fuente, J.
    Grupp, S.
    Handgretinger, R.
    Ho, T. W.
    Kattamis, A.
    Kernytsky, A.
    Lekstrom-Himes, J.
    Li, A. M.
    Locatelli, F.
    Mapara, M. Y.
    de Montalembert, M.
    Rondelli, D.
    Sharma, A.
    Sheth, S.
    Soni, S.
    Steinberg, M. H.
    Wall, D.
    Yen, A.
    Corbacioglu, S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03) : 252 - 260
  • [24] Genome-Editing Technologies: Principles and Applications
    Gaj, Thomas
    Sirk, Shannon J.
    Shui, Sai-lan
    Liu, Jia
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2016, 8 (12):
  • [25] ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
    Gaj, Thomas
    Gersbach, Charles A.
    Barbas, Carlos F., III
    [J]. TRENDS IN BIOTECHNOLOGY, 2013, 31 (07) : 397 - 405
  • [26] Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing
    Han, Hua Alexander
    Pang, Jeremy Kah Sheng
    Soh, Boon-Seng
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2020, 98 (05): : 615 - 632
  • [27] CRISPR-Cas: biology, mechanisms and relevance
    Hille, Frank
    Charpentier, Emmanuelle
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2016, 371 (1707)
  • [28] CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles
    Horodecka, Katarzyna
    Duchler, Markus
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [29] Development and Applications of CRISPR-Cas9 for Genome Engineering
    Hsu, Patrick D.
    Lander, Eric S.
    Zhang, Feng
    [J]. CELL, 2014, 157 (06) : 1262 - 1278
  • [30] Ibrahim AU, 2019, BIOMED PHARM SCI, V2, P1